Navigation Links
DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research
Date:6/12/2009

DNA Genotek to Provide Method for Easy, Reliable and Non-Invasive DNA Collection On-Site at Komen Western New York Race for the Cure®

Ottawa, ON (PRWEB) June 12, 2009 -- DNA Genotek, a leading provider of products for biological sample collection, today announced that it has partnered with the Roswell Park Cancer Institute (RPCI) to collect DNA saliva samples on-site at the Susan G. Komen Western New York Race for the Cure®. The race will be held this June 13th at the Delaware Park Rose Gardens in Buffalo, NY.

This event is the second of its kind under the "Spit for the Cure"™ umbrella and joins the very successful event initiated in 2007 by DNA Genotek, the Arkansas Affiliate of the Susan G. Komen for the Cure, and the University of Arkansas for Medical Sciences. Thousands of DNA samples have been collected at the Arkansas event.

The Komen Western New York Race for the Cure presents another excellent opportunity to accelerate breast cancer research. With more than 5,000 race participants expected, it will provide access to ideal candidates who satisfy donor profile requirements. The samples collected will become part of RPCI's Data Bank and BioRepository (DBBR) and used to augment cancer research.

Oragene®•DNA solves DNA sample collection problems inherent with traditional collection methods. Among many issues, traditional methods are too costly and invasive, or they do not reliably provide enough high quality DNA to enable health researchers to determine the underlying genetic cause of diseases like cancer, heart disease, and diabetes. In contrast, Oragene•DNA offers easy and non-invasive self-collection of saliva samples from large numbers of people. In addition, Oragene•DNA delivers high quality DNA that is stable at ambient temperature for years.

"The success of the initial Spit for the Cure event in Arkansas gave us the idea to recruit donor participants during the Western New York Race for the Cure to increase our bank of genetic samples", said Christine Ambrosone, PhD, Director, Data Bank and BioRepository, Roswell Park Cancer Institute". These genetic samples will allow us to further investigate the underlying genetic causes of breast cancer with the goal to improve diagnosis, assist prognosis and identify specific targets for therapeutic intervention. Participants will be enthusiastic about using Oragene•DNA to contribute a sample once they know it is easy, non-invasive and has the vast potential to unlock the mysteries of breast cancer."

"DNA Genotek is pleased to join forces with the Roswell Park Cancer Institute to collect samples on-site at the Western New York Race for the Cure event," said Ian Curry, President and CEO, DNA Genotek. "One of our primary goals is to deliver high quality products for researchers and clinicians all over the world to advance disease research, prevention and treatment. We are so pleased to assist in the collection of DNA samples at this event and we're proud of our long-term association with the successful Susan G. Komen Spit for the Cure events."

About the Roswell Park Cancer Institute:
Roswell Park Cancer Institute (RPCI) was established in 1898 on the principle of integrating clinical cancer care, cancer research and cancer education. RPCI was established as one of the first of the Comprehensive Cancer Centers by the National Cancer Institute (NCI) in 1974 and has held this designation continuously, since that time. RPCI is one of only a handful of free-standing NCI-designated comprehensive cancer centers in the country. The sole mission of the Institute is cancer research, treatment, prevention and education. The Institute devotes all of its resources, personnel, and facilities to supporting its cancer mission. For more information about the Roswell Park Cancer Institute, visit http://www.roswellpark.org/

About DNA Genotek:
DNA Genotek focuses on providing high-quality biological sample collection products. The company's lead product, the Oragene•DNA Self-Collection Kit, is the easiest way to collect and preserve large amounts of DNA from saliva. Oragene•DNA's reliability and ease-of-use have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 85 countries. For more information about DNA Genotek, visit www.dnagenotek.com

® Oragene is a registered trademark of DNA Genotek, Inc.
® Race for the Cure is a registered trademark of the Susan G. Komen for the Cure Foundation.
™ "Spit for the Cure" is a trademark of the Susan G. Komen for the Cure Organization.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2524674.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research
2. Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
3. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
4. AvePoint and OBS Forge Partnership
5. Neogen Partners With Chinese Government
6. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
7. ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
8. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
9. Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
10. The Hamner Institutes Announce Partnership With China Medical City
11. LS9 and Procter & Gamble Launch Sustainable Chemicals Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , February 12, 2016 ... Efforts by Enabling Scientific Understanding of Complex Diseases ... Rare Diseases --> ... diagnostics in South Asia and a leading provider of ... contribute $10 million to the GenomeAsia 100K consortium ...
(Date:2/11/2016)... Germany and GERMANTOWN, ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... RNA Panels for gene expression profiling, expanding QIAGEN,s portfolio ... The panels enable researchers to select from over 20,000 ... and discover interactions between genes, cellular phenotypes and disease ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, ... sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in the ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... than 150 years, continues today to pursue the highest level of accuracy and ... instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and tough ...
Breaking Biology Technology:
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/27/2016)... 2016  Rite Track, Inc. a leading semiconductor equipment ... Chester, Ohio announced today the acquisition of PLUS ... in Austin, Texas , will significantly ... modifications, installations and technical support offerings for TEL Track ... commented, "PLUS has provided world class service including refurbishment, ...
Breaking Biology News(10 mins):